Christopher H Gibbons MD
Neurophysiology
Associate Professor of Neurology, Harvard Medical School; Attending Neurologist, Beth Israel Deaconess Medical Center; Director, Neurocutaneous laboratory, Beth Israel Deaconess Medical Center; Director, Joslin Diabetes Center Neuropathy Clinic
Join to View Full Profile
1 Deaconess RdBeth Israel Deaconess Medical Center, Palmer 111Boston, MA 02215
Phone+1 617-632-8454
Fax+1 617-632-0852
Dr. Gibbons is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Harvard/MITMMSc, Medical Science, 2005 - 2007
Johns Hopkins UniversityResidency, Neurology, 2000 - 2003
Greenwich Hospital/Yale UniversityInternship, Internal Medicine, 1999 - 2000
Albert Einstein College of MedicineClass of 1999
Beth Israel Deaconess Medical Center/Children's Hospital/Harvard Medical SchoolFellowship, Clinical Neurophysiology
Certifications & Licensure
MA State Medical License 2004 - 2026
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3 Start of enrollment: 2018 Sep 01
Publications & Presentations
PubMed
- Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies-Reply.Christopher H Gibbons, Todd Levine, Roy Freeman
JAMA. 2024-08-27 - 9 citationsPhenoconversion in pure autonomic failure: a multicentre prospective longitudinal cohort study.Patricio Millar Vernetti, Lucy Norcliffe-Kaufmann, Jose-Alberto Palma, Italo Biaggioni, Cyndya A Shibao
Brain. 2024-07-05 - 1 citationsCutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis.Karla Cárdenas-Soto, Xel-Ha Dominguez, Giovanni Cortes, Felix Tsai, Maria Del Mar Saniger
Journal of the Peripheral Nervous System. 2024-06-01
Journal Articles
- State-of-the-Art ReviewRoy Freeman, Mitchell G Miglis, Christopher Gibbons, Pearl Jones, ScienceDirect
Press Mentions
CND Life Sciences to Present Updates from Three Clinical Trials Involving Their Skin Biopsy Diagnostic Tool for Dementia and Other Related Disorders at the American Academy of Neurology 2025 Annual MeetingMarch 27th, 2025- Syn-One Test Can Diagnose Parkinson’s via Skin BiopsyMay 9th, 2023
- AAN 2023: Skin Test Ably Detects Alpha-Synuclein Clumps in TrialMay 2nd, 2023
- Join now to see all
Grant Support
- Structure &Function In Diabetic Small Fiber NeuropathyNational Institute Of Neurological Disorders And Stroke2008–2012
- Structure And Function: Diabetic Small Fiber NeuropathyNational Institute Of Neurological Disorders And Stroke2004–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
